Cartesian Therapeutics Inc. (1S70)
Market Closed
18 Jul, 20:00
XBER 
NASDAQ (NMS) Primary XBER €
10. 40
-0.5
-4.59%
€
100.82M Market Cap
- P/E Ratio
0% Div Yield
0 Volume
- Eps
€ 10.9
Previous Close Day Range
10.3 10.8
Year Range
7.6 24.6
Want to track 1S70 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 24 days
 RNAC Cartesian Therapeutics Inc. 14 Aug 2025 (In 3 weeks) | | - Cons. EPS | - EPS |
| RNAC Cartesian Therapeutics Inc. 6 May 2025 | | - Cons. EPS | - EPS |
| RNAC Cartesian Therapeutics Inc. 5 Mar 2025 | | - Cons. EPS | - EPS |
| RNAC Cartesian Therapeutics Inc. 11 Nov 2024 | | - Cons. EPS | - EPS |
| RNAC Cartesian Therapeutics Inc. 15 Aug 2024 | | - Cons. EPS | 0.54 EPS |
| RNAC Cartesian Therapeutics Inc. 8 Aug 2024 | | - Cons. EPS | 0.54 EPS |
| RNAC Cartesian Therapeutics Inc. 14 Jun 2024 | | - Cons. EPS | - EPS |
| RNAC Cartesian Therapeutics Inc. 20 May 2024 | | - Cons. EPS | - EPS |
| RNAC Cartesian Therapeutics Inc. 2 May 2024 | | - Cons. EPS | - EPS |
| RNAC Cartesian Therapeutics Inc. 7 Mar 2024 | | - Cons. EPS | - EPS |
| RNAC Cartesian Therapeutics Inc. 6 Mar 2024 | | - Cons. EPS | - EPS |
| RNAC Cartesian Therapeutics Inc. 4 Mar 2024 | | - Cons. EPS | - EPS |
| RNAC Cartesian Therapeutics Inc. 1 Mar 2024 | | - Cons. EPS | - EPS |
| RNAC Cartesian Therapeutics Inc. 29 Feb 2024 | | - Cons. EPS | - EPS |
1S70 Earnings Reports FAQ
2025 © Marketlog. All Rights Reserved.
